Chordate Medical Holding AB (OSTO:CMH) Dividends per Share : kr0.00 (TTM As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Chordate Medical Holding AB Dividends per Share?

Chordate Medical Holding AB's dividends per share for the three months ended in Dec. 2023 was kr0.00. Its dividends per share for the trailing twelve months (TTM) ended in Dec. 2023 was kr0.00. Its Dividend Payout Ratio for the three months ended in Dec. 2023 was 0.00. As of today, Chordate Medical Holding AB's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

Chordate Medical Holding AB Dividends per Share Historical Data

The historical data trend for Chordate Medical Holding AB's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chordate Medical Holding AB Dividends per Share Chart

Chordate Medical Holding AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dividends per Share

Get a 7-Day Free Trial

Chordate Medical Holding AB Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Dividends per Share	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Chordate Medical Holding AB's Dividends per Share

For the Medical Devices subindustry, Chordate Medical Holding AB's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Chordate Medical Holding AB's Dividend Yield % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Chordate Medical Holding AB's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Chordate Medical Holding AB's Dividend Yield % falls into.

Chordate Medical Holding AB Dividends per Share Calculation

Dividends paid to per common share.

Chordate Medical Holding AB (OSTO:CMH) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Chordate Medical Holding AB's Dividend Payout Ratio for the quarter that ended in Dec. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Dec. 2023 )	/	EPS without NRI (Q: Dec. 2023 )
	=	0	/	-0.038
	=	N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Chordate Medical Holding AB Dividends per Share Related Terms

Thank you for viewing the detailed overview of Chordate Medical Holding AB's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Chordate Medical Holding AB (OSTO:CMH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Chordate Medical Holding AB (OSTO:CMH) » Definitions » Dividends per Share

Comparable Companies

Traded in Other Exchanges

K1Z:Germany

Address

c/o Regus, Kistagangen 20B, Kista, SWE, 164 40

Website

https://www.chordate.com

Chordate Medical Holding AB is a medical technology company that has developed and patented and CE-marked a new nerve-modulating treatment technology for chronic nasal congestion and chronic migraine. The company sells its products in Selected European markets, Israel and Saudi Arabia. The company's product range is based on the CE-marked treatment units Chordate System S100 and S120 for rhinitis and S220 for migraine, registered for the indications of preventive treatment of chronic migraine and chronic rhinitis and use on patients who are 18 years old or older. The company sells its product system, including treatments, through distributors to clinics and hospitals in its primary markets.

Chordate Medical Holding AB (OSTO:CMH) Headlines

No Headlines